← Back
$OCUL All transactions

OCULAR THERAPEUTIX, INC

▼ SELL

$ Value

$23K

Shares

1,885

Price

$12

Filed

Aug 27

Insider

Name

Nayak Sanjay

Title

Chief Strategy Officer

CIK

0002012715

Roles

Officer

Transaction Details

Transaction Date

2025-08-25

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

279,738

Footnotes

Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.1521, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Filing Info

Accession No.

0001104659-25-084116

Form Type

4

Issuer CIK

0001393434

Nayak Sanjay's History

Date Ticker Type Value
2026-02-23 OCUL $15K
2026-02-12 OCUL $94K
2026-01-02 OCUL A $0
2026-01-02 OCUL A $0
2025-11-24 OCUL $23K
2025-08-25 OCUL $23K
2025-05-23 OCUL $13K

Other Insiders at OCUL (90d)

Insider Bought Sold Last
LINDSTROM RICHARD L MD $461K 2026-02-20
Heier Jeffrey S.
Chief Scientific Officer
$25K 2026-02-23
Dugel Pravin
See Remarks
$1.3M 2026-04-09
Notman Donald
Chief Operating Officer
$205K 2026-02-12
Kaiser Peter
Chief Development Officer
$23K 2026-02-23
Nayak Sanjay
Chief Strategy Officer
$108K 2026-02-23
Waheed Nadia
Chief Medical Officer
$98K 2026-02-20
Robinson David Wayne
Global CCO
2026-01-21